CIRBP protects H9C2 cells against myocardial ischemia through inhibition of NF-κB pathway

T Y Long1, R Jing1, F Kuang2

  • 1Cardiovascular Department, The Xiangya Hospital of Central South University, Changsha City, Hunan Province, China.

Insights

Cold inducible RNA-binding protein (CIRBP) protects against myocardial ischemia by inhibiting the NF-κB pathway. Overexpressing CIRBP enhances cell viability and reduces apoptosis and reactive oxygen species (ROS) in ischemic conditions.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Cell Biology

Background:

  • Myocardial ischemia is a leading cause of mortality with limited therapeutic options.
  • Cold inducible RNA-binding protein (CIRBP) is implicated in various pathological processes, including myocardial ischemia.
  • The precise molecular mechanisms underlying myocardial ischemia require further elucidation.

Purpose of the Study:

  • To investigate the role and molecular mechanisms of Cold inducible RNA-binding protein (CIRBP) in myocardial ischemia.
  • To determine if CIRBP can protect against myocardial ischemia in a cellular model.

Main Methods:

  • Overexpression and silencing of CIRBP in H9C2 cells.
  • Construction of a H9C2 cell model of myocardial ischemia using serum-free medium and hypoxia.
  • Assessment of cell viability (AlamarBlue assay), reactive oxygen species (ROS) levels, apoptosis (flow cytometry), and protein expression (Western blot) of IκBα, p65, and Bcl-3.

Main Results:

  • CIRBP overexpression significantly increased cell proliferation and Bcl-3 expression while inhibiting apoptosis and reducing ROS levels.
  • CIRBP overexpression also down-regulated phosphorylated levels of IκBα and p65, indicating NF-κB pathway inhibition.
  • CIRBP knockdown produced opposite effects, confirming its protective role.

Conclusions:

  • Cold inducible RNA-binding protein (CIRBP) demonstrates a protective effect against myocardial ischemia in H9C2 cells.
  • CIRBP exerts its protective function by inhibiting the NF-κB signaling pathway.
  • These findings suggest CIRBP as a potential therapeutic target for myocardial ischemia.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.2K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
667
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
3.1K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.0K